Scientists reveal that reactivation of Epstein-Barr virus (EBV), driven by TGFβ-induced immune suppression, is a key driver ...

Certain immune cells in MS show abnormalities in activity and signs of reactions against the Epstein-Barr virus, a study says ...

The Wistar Institute's Paul M. Lieberman, Ph.D. and lab identified and tested a new method for targeting certain cancers ...

New research highlights a critical link between antibodies produced against Epstein-Barr virus (EBV) and the development of ...

A new study reveals that Epstein-Barr virus (EBV) infection exacerbates ulcerative colitis (UC) by driving macrophage pyroptosis through the upregulation of glycolysis. This finding provides a ...

In multiple sclerosis (MS), antibodies to the common Epstein-Barr virus can accidentally attack a protein in the brain and ...

A new study highlights a previously existing, dormant infection with the Epstein-Barr virus becomes reactive and triggers an ...

EBV antibodies trigger MS by attacking brain proteins. Genetic factors worsen risk. Breakthrough insights for treatment.

New research reveals that Epstein-Barr virus reactivation, triggered by COVID, may cause MIS-C in children. MIS-C is a severe ...

Multisystem inflammatory syndrome in children (MIS-C), a serious disorder that develops after SARS-CoV-2 infection, could ...

The risk of developing MS and other demyelinating diseases is 3 times greater in individuals diagnosed with EBV-positive IM.

New research shows that the combination of certain viral antibodies and genetic risk factors can be linked to a greatly ...